However, the substantial weight loss it produces may indirectly affect bone metabolism through reduced mechanical loading and potential nutritional changes
In the Tirzepatide versus Semaglutide cohort of 25,060 matched pairs, no statistically significant differences emerged across ocular outcomes, though Tirzepatide showed a non-significant trend (HR 0.87, 95% CI: 0.551.37, p = 0.540
[Accessed 7th of July 2025]
Some patients find that they need to stay at lower doses for months before their body tolerates escalation
By slowing down and being mindful while eating, your body has time to signal fullness before youve overeaten, and this also reduces the likelihood of nausea or bloating
This synergy is the reason tirzepatide consistently outperforms GLP-1 only medications in head-to-head comparisons